scholarly journals Advances in prevention and treatment of digestive tract damage induced by antithrombotic therapy with traditional Chinese and Western medicine

2021 ◽  
Vol 29 (19) ◽  
pp. 1089-1095
Author(s):  
Kai-Hong Yi ◽  
Xue-Rui Tan
Keyword(s):  
Digestive Tract ◽  
Western Medicine ◽  
Antithrombotic Therapy ◽  
Prevention And Treatment ◽  
Tract Damage

Digestive Tract Damage

2018 ◽  
Vol 61 (2) ◽  
pp. 147-148
Author(s):  
Evangelos Messaris
Keyword(s):  
Digestive Tract ◽  
Tract Damage

scholarly journals Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis

2020 ◽  
Author(s):  
R. H. Olie ◽  
P. E. J. van der Meijden ◽  
H. M. H. Spronk ◽  
H. ten Cate
Keyword(s):  
Antithrombotic Therapy ◽  
Prevention And Treatment

scholarly journals The problem of coccidiosis in broiler chickens and laying hens: Selected control methods and alternative solutions

2021 ◽  
Vol 77 (09) ◽  
pp. 6571-2021
Author(s):  
KAROLINA FABIA ◽  
DARIUSZ WOLSKI ◽  
MAREK BIEŃKO ◽  
RADOSŁAW P. RADZKI ◽  
SYLWIA SZYMAŃCZYK
Keyword(s):  
Weight Gain ◽  
Digestive Tract ◽  
Broiler Chickens ◽  
Economic Problem ◽  
Poultry Production ◽  
Control Methods ◽  
Negative Effects ◽  
Prevention And Treatment ◽  
Alternative Solutions ◽  
Disease Unit

In industrial poultry production, especially in broiler chickens, coccidiosis, caused by Eimeria protozoa parasites in the digestive tract, continues to be a serious health and economic problem. In economic terms, the losses are mainly caused by the costs of prevention and treatment, as well as the reduced weight gain and reduced condition of the birds. Currently, the prophylactic program of this disease unit is mainly based on the use of chemotherapeutics. Another way to control coccidiosis is active immunoprophylaxis, based on the vaccination of chickens for fattening, and passive immunoprophylaxis, based on vaccination of the parent flock. An alternative, effective way to reduce the negative effects of protozoan infestation by Eimeria may be the use of herbs and their extracts, pre- and probiotics and betaine.

scholarly journals Retrospective Review of Traditional Chinese Medicine Treatment of COVID-19 in China: Clinical Practice and Researches

2021 ◽  
Vol 2021 (1) ◽  
Author(s):  
Han Lai ◽  
Hui Zhang
Keyword(s):  
Chinese Medicine ◽  
Herbal Medicine ◽  
Traditional Chinese Medicine ◽  
Western Medicine ◽  
Treatment Protocol ◽  
Medical Community ◽  
Critical Conditions ◽  
Syndrome Differentiation ◽  
National Guidance ◽  
Prevention And Treatment

In the fight against COVID-19 in China, traditional Chinese medicine (TCM) has played an important role in relieving symptoms, preventing deterioration, improving cure rate, reducing death rate, and promoting recovery. Since the third edition of the Diagnosis and Treatment Protocol for COVID-19 (simply referred to as the National Protocol), TCM has been included in the national guidance to tackle the epidemic. In order to make the international medical community fully understand the experience of TCM in the prevention and treatment of COVID-19, we comprehensively reviewed the history, etiology and pathogenesis, prevention and treatment, rehabilitation, and clinical and pharmacological research of TCM used in the endemic. The COVID-19 is under the category of plague or pestilence in TCM. Herbal medicine treatment for COVID-19 is mainly performed based on the syndrome differentiation of three stages and four types. The method also applies to acupuncture and moxibustion treatments. Herbal medicine granules and injections are used flexibly, and Western medicine is adopted to rescue patients in critical conditions. In rehabilitation, the integration of Chinese and Western medicine can be used to improve the respiratory and somatic function of patients. The role TCM has been playing in fighting this epidemic is a further proof of the effect of TCM in preventing and treating infectious diseases, and the relevant experience has been summarized and sublimated.

Thromboembolic Disease and Antithrombotic Therapy in Newborns

Hematology ◽  
2001 ◽  
Vol 2001 (1) ◽  
pp. 358-374 ◽  
Author(s):  
Maureen E. Andrew ◽  
Paul Monagle ◽  
Gabrielle deVeber ◽  
Anthony K.C. Chan
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Antithrombotic Therapy ◽  
In Utero ◽  
Therapeutic Approaches ◽  
Arterial Ischemic Stroke ◽  
Prevention And Treatment ◽  
Sinovenous Thrombosis ◽  
The Central Nervous System ◽  
Neurological Presentation

Abstract This update uses an evidence based approach to analyze and present the epidemiology of neonatal thrombosis, etiologies, currently used techniques for diagnosis with their limitations, and current therapeutic approaches. In addition, the approaches to both prevention and optimal therapies are discussed. In Section I Dr. Paul Monagle addresses the epidemiology of neonatal thrombosis outside of the central nervous system in both arterial and venous locations, and those that occur in utero. The specific contributions of catheters and congenital prothrombotic disorders are delineated. Dr. Monagle also describes currently used techniques for the diagnosis of thrombotic events as well as their limitations and the current therapeutic approaches. In Section II, Dr. Gabrielle deVeber reviews the epidemiology of neonatal thrombosis within the central nervous system, in both arterial and venous locations and those that occur in utero. The neurological presentation, risk factors including congenital prothrombotic disorders, anatomical distribution, diagnostic tests, use of antithrombotic therapy and neurologic outcome of neonates with either sinovenous thrombosis or arterial ischemic stroke are discussed. In Section III, Dr. Anthony Chan reviews the current approaches to the prevention and treatment of neonatal thrombosis. Information on the differences in the response of neonates compared to adults to antithrombotic therapy and new approaches to the prevention and treatment of thrombosis in neonates are emphasized.

scholarly journals Duodenal damage complicating percutaneous access to kidney

2000 ◽  
Vol 118 (4) ◽  
pp. 116-117 ◽  
Author(s):  
Antonio Corrêa Lopes Neto ◽  
Marcos Tobias-Machado ◽  
Roberto Vaz Juliano ◽  
Marco Aurélio Lipay ◽  
Milton Borrelli ◽  
...  
Keyword(s):  
Case Report ◽  
Conservative Treatment ◽  
Digestive Tract ◽  
Percutaneous Nephrostomy ◽  
Surgical Exploration ◽  
Duodenal Lesion ◽  
Percutaneous Access ◽  
Technical Advances ◽  
Design Case ◽  
Tract Damage

CONTEXT: Since the first percutaneous nephrostomy performed by Goodwin in 1954, technical advances in accessing the kidneys via percutaneous puncture have increased the use of this procedure and thus the complications too. Among these complications, digestive tract damage is not common. DESIGN: Case report. CASE REPORT: We report a duodenal lesion that was corrected using surgical exploration and we touch on the therapeutic options, which may be conservative or interventionist. We chose conservative treatment, which has been approached in diverse manners in the literature.

Sign in / Sign up

Export Citation Format

Share Document